MerTK is a novel therapeutic target in gastric cancer.

about

MerTK inhibition by RXDX-106 in MerTK activated gastric cancer cell lines.The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma.The TAM family as a therapeutic target in combination with radiation therapy

P2860

Q47106713-876F99E5-32B8-461C-86F0-7260D6DAC782 Q52648382-A8386782-DB1D-4B7A-809D-097622E29A4E Q56795847-7F11BF16-5936-4848-89CD-AC1CDD31CD08

P2860

MerTK is a novel therapeutic target in gastric cancer.

Item

http://www.wikidata.org/entity/Q47146130

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

MerTK is a novel therapeutic target in gastric cancer.

@en

MerTK is a novel therapeutic target in gastric cancer.

@nl

type

Item

label

MerTK is a novel therapeutic target in gastric cancer.

@en

MerTK is a novel therapeutic target in gastric cancer.

@nl

prefLabel

MerTK is a novel therapeutic target in gastric cancer.

@en

MerTK is a novel therapeutic target in gastric cancer.

@nl

P1476

MerTK is a novel therapeutic target in gastric cancer.

@en

P2093

Ho Yeong Lim

http://www.w3.org/2001/XMLSchema#string

In-Gu Do

http://www.w3.org/2001/XMLSchema#string

Jeeyun Lee

http://www.w3.org/2001/XMLSchema#string

Jeonghee Cho

http://www.w3.org/2001/XMLSchema#string

Jiryeon Jang

http://www.w3.org/2001/XMLSchema#string

Joon Oh Park

http://www.w3.org/2001/XMLSchema#string

Jun Ho Yi

http://www.w3.org/2001/XMLSchema#string

Kyoung-Mee Kim

http://www.w3.org/2001/XMLSchema#string

Mineui Hong

http://www.w3.org/2001/XMLSchema#string

Se Hoon Park

http://www.w3.org/2001/XMLSchema#string

P2860

Chemotherapy for advanced gastric cancer

Cloning and mRNA expression analysis of a novel human protooncogene, c-mer

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia

Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer

Patterns of somatic mutation in human cancer genomes

Comprehensive analysis of kinase inhibitor selectivity

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

MERTK receptor tyrosine kinase is a therapeutic target in melanoma.

P304

96656-96667

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3750

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276208453

http://www.w3.org/2001/XMLSchema#string

P698

29228560

http://www.w3.org/2001/XMLSchema#string

P932

5722512

http://www.w3.org/2001/XMLSchema#string

MerTK is a novel therapeutic target in gastric cancer.

about

P2860

P2860

MerTK is a novel therapeutic target in gastric cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932